anonymous
Guest
anonymous
Guest
Well, we all saw the slides, 10 years ago, "full-potential" by 2022. Hasn't really happened, has it. Just today, Bank of America has downgraded Amgen. Bob, maybe it's time to go.
I know you can’t see it in your little quaint individual contributor bubble, but Bob is actually a really smart dude. Shows great leadership qualities around his table as well.
I don’t expect you to get it but if you participated or observed him in his engagements, you’d actually find him a great leader for our organization.
There are gaps below for sure- the root cause of which Amgen doesn’t cross pollinate leaders between functions, so when you get to a certain level they become so myopic to their functional kingdom. Bob tries remediate but can only do so much.
Never hear of themBring back Mike Nohaile and Kristin Yarema!
OP - what have you done in the past 10 years, let's compare.
Junior, I don't think you get it, Amgen is a publicaly held company, literally owned by investors. Unless the stock goes up, Bob (and patients) fail. Business success as shown by valuation drives inovation, ask biogen.OP - what have you done in the past 10 years, let's compare.
Junior, I don't think you get it, Amgen is a publicaly held company, literally owned by investors. Unless the stock goes up, Bob (and patients) fail. Business success as shown by valuation drives inovation, ask biogen.
Great points. They would be more impactful if you could spell.
Maybe your point would be too if you didn’t use a made up buzzword from the 60’s that makes most grammatists cringe when seeing or hearing…look it up.
Bob can take a 1 year vacation and nothing would change. That is the best way to confirm that the guy is worthless
True. The lion doesn't care about the goings on of the dung beetles.You all seem to be missing the point; look at the trend in Amgen's stock price over the past 10 years and then the 10 years preceding it... For those that really matter to the Company, there aren't many complaints to be had.
Ten years ago the only thing Bob did was to called all his friends in the investment and banking industry and asked them to buy Amgen stock since he sold them a beautiful future.You all seem to be missing the point; look at the trend in Amgen's stock price over the past 10 years and then the 10 years preceding it... For those that really matter to the Company, there aren't many complaints to be had.